ITEM 8.01 OTHER EVENTS.
On
A copy of the Company's press release announcing the signing of a definitive agreement to acquire Preventice is included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference; provided, however, that information on or connected to our website or the website of any third-party hyperlinked from or referenced in the Company's press release included as Exhibit 99.1 to this Current Report on Form 8-K is expressly not incorporated by reference into or intended to be filed as a part of this Current Report on Form 8-K.
Cautionary Statement Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our business plans, regulatory approvals, the closing of the acquisition, product development and product performance and impact. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.
Factors that may cause such differences include, among other things: future
economic, competitive, reimbursement and regulatory conditions; new product
introductions; demographic trends; intellectual property; litigation; financial
market conditions; and future business decisions made by us and our competitors.
All of these factors are difficult or impossible to predict accurately and many
of them are beyond our control. For a further list and description of these and
other important risks and uncertainties that may affect our future operations,
see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K
filed with the
Use of Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a GAAP basis,
we disclose certain non-GAAP financial measures, including adjusted net income
(loss), adjusted net income (loss) available to common stockholders and adjusted
net income (loss) per share that excludes certain charges and/or credits, such
as amortization expense, acquisition-related net charges (credits) and
investment impairment net charges (credits). These non-GAAP financial measures
are not in accordance with generally accepted accounting principles in
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
--------------------------------------------------------------------------------
Exhibit No. Description Press Release issued byBoston Scientific Corporation , datedJanuary 21 , 99.1 2021 Cover Page Interactive Data File - the cover page XBRL tags are embedded 104 within the Inline XBRL document
--------------------------------------------------------------------------------
© Edgar Online, source